Privia Health Group, Inc. (NASDAQ: PRVA) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $25.00 price target on the stock.
Privia Health to Report First Quarter 2024 Results on Thursday, May 9 [Yahoo! Finance]
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
Global Corporate Wellness Market Poised for Substantial Growth, Expected to Surpass USD 177 Billion by 2034 [Yahoo! Finance]
Privia Health Group, Inc. (NASDAQ: PRVA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $41.00 to $37.00. They now have a "buy" rating on the stock.